SG/CALL/BRISTOL-MYERS SQUIBB/65/0.1/20.12.24 Stock SG/CALL/BRISTOL-MYERS SQUIBB/65/0.1/20.12.24
Add to a list
To use this feature you must be a member
Log inSign up

SG/CALL/BRISTOL-MYERS SQUIBB/65/0.1/20.12.24 Stock

Warrant

DE000SW8AVZ7

Real-time Bid/Ask 12:11:50 2024-06-03 EDT
0.012 EUR / 0.022 EUR +183.33% Intraday chart for SG/CALL/BRISTOL-MYERS SQUIBB/65/0.1/20.12.24
1 month-64.71%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart BRISTOL-MYERS SQUIBB COMPANY
Chart SG/CALL/BRISTOL-MYERS SQUIBB/65/0.1/20.12.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting BU
Bristol Myers: presents advances in lung cancer CF
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer BU
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes RE
More news

Quotes 5-day view

Date Price Change
24-06-03 0.009 +50.00%
24-05-31 0.006 -25.00%
24-05-30 0.008 +14.29%
24-05-29 0.007 0.00%
24-05-28 0.007 0.00%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 04:12 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BRISTOL-MYERS SQUIBB COMPANY
IssuerLogo Issuer Société Générale Société Générale
WKN SW8AVZ
ISINDE000SW8AVZ7
Date issued 2024-03-27
Strike 65 $
Maturity 2024-12-20 (200 Days)
Parity 10 : 1
Emission price 0.091 €
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.093 €
Lowest since issue 0.006 €
Delta0.05x
Omega 10.48
Premium55.9x
Gearing213.36x
Moneyness 0.6434
Difference Strike 23.12 $
Difference Strike %+35.58%
Spread 0.01 €
Spread %43.48%
Theoretical value 0.0180
Implied Volatility 33.56 %
Total Loss Probability 97.08 %
Intrinsic value 0.000000
Present value 0.0180
Break even 65.20 €
Theta-0x
Vega0x
Rho0x

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Sector
-
More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Bristol-Myers Squibb Company

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09 USD
Average target price
53.19 USD
Spread / Average Target
+29.46%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant